PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
297.09%
Net income growth under 50% of AVGO's 878.54%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
2.23%
Some D&A expansion while AVGO is negative at -2.87%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-119.50%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
55.56%
SBC growth well above AVGO's 18.65%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-141.72%
Both reduce yoy usage, with AVGO at -310.61%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-158.86%
AR is negative yoy while AVGO is 741.94%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-97.96%
Negative yoy inventory while AVGO is 1662.50%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-172.86%
Both negative yoy AP, with AVGO at -539.68%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-118.17%
Both reduce yoy usage, with AVGO at -250.32%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-282.14%
Negative yoy while AVGO is 62.54%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-42.35%
Both yoy CFO lines are negative, with AVGO at -13.99%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
18.18%
CapEx growth well above AVGO's 5.58%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with AVGO at -1010.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
31.31%
Some yoy expansion while AVGO is negative at -3385.71%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
84.18%
Proceeds from sales/maturities above 1.5x AVGO's 18.50%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
98.32%
Less 'other investing' outflow yoy vs. AVGO's 200.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
129.62%
We have mild expansions while AVGO is negative at -1167.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment 1.25-1.5x AVGO's 78.40%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
9.88%
We slightly raise equity while AVGO is negative at -48.48%. John Neff sees competitor possibly preserving share count or buying back shares.
-23.65%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.